Literature DB >> 26394670

Identification and Susceptibility Testing From Shortly Incubated Cultures Accelerate Blood Culture Diagnostics at No Cost.

Evgeny A Idelevich1, Karsten Becker1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26394670     DOI: 10.1093/cid/civ824

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

1.  Rapid Identification of Microorganisms from Positive Blood Culture by MALDI-TOF MS After Short-Term Incubation on Solid Medium.

Authors:  Antonio Curtoni; Raffaella Cipriani; Elisa Simona Marra; Anna Maria Barbui; Rossana Cavallo; Cristina Costa
Journal:  Curr Microbiol       Date:  2016-11-17       Impact factor: 2.188

2.  Direct blood culturing on solid medium outperforms an automated continuously monitored broth-based blood culture system in terms of time to identification and susceptibility testing.

Authors:  E A Idelevich; B Grünastel; G Peters; K Becker
Journal:  New Microbes New Infect       Date:  2015-12-23

3.  Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy.

Authors:  Robin Köck; Jörg Wüllenweber; Dagmar Horn; Christian Lanckohr; Karsten Becker; Evgeny A Idelevich
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-14       Impact factor: 4.887

Review 4.  The new frontier of diagnostics: Molecular assays and their role in infection prevention and control.

Authors:  Sanchita Das; Dena R Shibib; Michael O Vernon
Journal:  Am J Infect Control       Date:  2017-02-01       Impact factor: 2.918

5.  Direct Identification, Antimicrobial Susceptibility Testing, and Extended-Spectrum β-Lactamase and Carbapenemase Detection in Gram-Negative Bacteria Isolated from Blood Cultures.

Authors:  Hainan Wen; Shoujun Xie; Yueyi Liang; Yanchao Liu; Honglian Wei; Qian Sun; Weigang Wang; Baojiang Wen; Jianhong Zhao
Journal:  Infect Drug Resist       Date:  2022-04-06       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.